Working… Menu

Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02523014
Recruitment Status : Suspended (No arms are currently open to patient registration)
First Posted : August 14, 2015
Last Update Posted : August 17, 2021
National Cancer Institute (NCI)
Genentech, Inc.
Brain Science Foundation
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : October 2024
Study Completion Date : No date given